GENET-news articles on GE rabbits
2010-02-19 | permalink
Pharming confident of Rhucin Europe approval in 2010 despite EUR 32.1 mill loss in 2009
Dutch biotechnology firm Pharming said it was on track to secure European approval for its key drug product Rhucin, even as it continued to operate at a loss for 2009. Pharming, which produces therapeutic proteins in the milk of genetically modified animals, reported on Thursday a net loss of 32.1 million euros ($44.07 million) in 2009 compared with a loss of 26.2 million in 2008, partly due to lower interest income.
Overview
2010-02-19 | permalink
Pharming confident of Rhucin Europe approval in 2010 despite EUR 32.1 mill loss in 2009
Dutch biotechnology firm Pharming said it was on track to secure European approval for its key drug product Rhucin, even as it continued to operate at a loss for 2009. Pharming, which produces therapeutic proteins in the milk of genetically modified animals, reported on Thursday a net loss of 32.1 million euros ($44.07 million) in 2009 compared with a loss of 26.2 million in 2008, partly due to lower interest income.
